Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Study identifies key gluten peptide triggering leaky gut in celiac patients

Today is International Celiac Day. Celiac disease is a chronic autoimmune condition that occurs in around one per cent of the world's population. It is triggered by the consumption of gluten proteins from wheat, barley, rye and some oats. A gluten-free diet pr

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Today is International Celiac Day. Celiac disease is a chronic autoimmune condition that occurs in around one per cent of the world's population. It is triggered by the consumption of gluten proteins from wheat, barley, rye and some oats. A gluten-free diet protects celiac patients from severe intestinal damage. Together with colleagues, chemist Dr Veronica Dodero from Bielefeld University was able to determine new details on how certain gluten-derived molecules trigger leaky gut syndrome in celiac disease.

The key finding of the study: a particular protein fragment formed in active celiac disease forms nanosized structures, the so-called oligomers, and accumulates in a gut epithelial cell model. The technical name of the molecule is 33-mer deamidated gliadin peptide (DGP). The study team has now discovered that the presence of DGP oligomers may open the tightly closed gut lining, leading to the leaky gut syndrome. The study has now been published in the journal 'Angewandte Chemie'.

Wheat peptides causing leaky gut

When we eat wheat, our bodies cannot completely break down gluten proteins. This can lead to the formation of large gluten fragments (peptides) in our gut. In cases of active coeliac disease, researchers discovered that the enzyme tissue transglutaminase 2 (tTG2) present in humans modifies a specific gluten peptide, resulting in the formation of the 33-mer DGP. This usually happens in a part of our gut called the lamina propria. However, recent research has shown that this process can also occur in the gut lining.

'Our interdisciplinary team characterized the formation of 33-mer DGP oligomers through high-resolution microscopy and biophysical techniques. We discovered the increased permeability in a gut cell model when DGP accumulates, reports Dr. Maria Georgina Herrera, the first author of the study. She is researcher at the University of Buenos Aires in Argentina and was a postdoctoral fellow at Bielefeld.

When the intestinal barrier is weakened

Leaky gut syndrome occurs when the lining of the intestine becomes permeable, allowing harmful substances to enter the bloodstream, leading to inflammatory responses and different diseases. In celiac disease, there's debate about the early stages of increased permeability. The mainstream theory suggests that chronic inflammation in coeliac disease leads to a leaky gut. However, there is a second theory that proposes that gluten's effects on gut lining cells are the primary cause. In this view, gluten directly damages the cells of the intestinal lining, making them permeable, which triggers chronic inflammation and potentially leads to celiac disease in predisposed people.

However, since gluten is consumed daily, what molecular triggers lead to the leaky gut in celiac disease patients? If 33-merDGP oligomers are formed, they may damage the epithelial cell network, allowing gluten peptides, bacteria, and other toxins to pass massively into the bloodstream, leading to inflammation and, in celiac disease, autoimmunity.

'Our findings reinforce the medical hypothesis that impairment of the epithelial barrier promoted by gluten peptides is a cause and not a result of the immune response in celiac patients,' says the lead author of the study, Dr Veronica Dodero from the Bielefeld Faculty of Chemistry.

The relationship between 33-mer DGP and celiac disease

Human leukocyte antigens (HLAs) are proteins found on the surface of cells in the body. They play a crucial role in the immune system by helping it distinguish between self (the body's own cells) and non-self (foreign substances like bacteria or viruses). In celiac disease, two specific HLA proteins, namely HLA-DQ2 and HLA-DQ8, are strongly associated with the condition. The 33-mer DGP fits perfectly with HLA-DQ2 or HLA-DQ8 and triggers an immune response, leading to inflammation and small intestine villous atrophy. This strong interaction turns the DGP into what scientists call a superantigen. For those affected, a gluten-free diet is the only lifelong therapy.

'Angewandte Chemie'

This publication is one of the most renowned journals in the field of chemistry. It is published by the Society of German Chemists. According to the Clarivate data service, the journal has an impact factor of 16.6 (2022). This makes it one of the most influential publications in its field.

Herrera, M. G., et al. (2024). The Celiac‐Disease Superantigen Oligomerizes and Increases Permeability in an Enterocyte Cell Model. Angewandte Chemie. doi.org/10.1002/anie.202317552.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Could we one day get rid of food allergies?

These seed epitopes are an exciting new addition to our understanding of oral tolerance. Scientists have already considered regulatory T cells as a promising immunotherapy route for people with severe food allergies. It may one day be possible to create regulatory T cells that are pre-programmed to tolerate certain foods and dampen immune responses to common allergens. "Diet is our most intimate interaction with our environment," says Blum. "Correctly recognizing foods as safe creates an anti-inflammatory environment to support nutrient acquisition and prevent allergy. Our research advances scientific understanding of the major dietary allergens, and points us toward future therapeutic interventions that could redirect allergic and autoimmune states." In the less-distant future, the researchers are excited to see their workflow for mapping proteins adapted to humans. The reagent they developed to track their proteins is now available for others to use, so they're hopeful that new insights into regulatory T cell-mediated oral tolerance are soon to come. Blum J. E., et al. (2026). Identification and characterization of dietary antigens in oral tolerance. Science Immunology. DOI: 10.1126/sciimmunol.aeb4684, https://www.science.org/doi/10.1126/sciimmunol.aeb4684.

Source: www.news-medical.net ↗
02Do BCAA Supplements Increase Muscle Mass?

There is mixed evidence regarding the effectiveness of BCAA supplements to increase muscle mass in its users. Research investigating such effects between those who took BCAA supplements and a placebo found that those who took the supplement reported increase energy metabolism and reduced levels of substances attributed to muscle damage. However, other researchers proposed there is a lack of consensus regarding the effects of BCAAs as a nutritional supplement. Despite disagreement in the scientific literature, it is indicated that potential overconsumption of BCAAs may pose health risks. However, more research is needed to further investigate the impact of both typical and excessive consumption.

Source: www.news-medical.net ↗
03What are Introns?

Introns are nucleotide sequences in DNA and RNA that do not directly code for proteins, and are removed during the precursor messenger RNA (pre-mRNA) stage of maturation of mRNA by RNA splicing. Introns can range in size from 10’s of base pairs to 1000’s of base pairs, and can be found in a wide variety of genes that generate RNA in most living organisms, including viruses. Four distinct types of introns have been identified:

Source: www.news-medical.net ↗
04In practical drug discovery and safety projects, where do graph-based models outperform traditional quantitative structure-activity relationship (QSAR) approaches, and where do conventional methods still offer advantages?

For molecular design, classical machine learning with traditional fingerprints is not going to generate accurate 3D structures in the way modern graph-based, diffusion, and foundation models can. Where we have large, high-quality datasets, graph neural networks, language models, and foundation models can also outperform classical methods for property prediction. We even see some attempts at generating very large and widely applicable QSAR models, although bespoke models for specific target chemistries and properties remain the main form of QSAR model in use today. However, classical machine learning models are still very useful, especially for small datasets, which are common in early discovery. Classical machine learning models often have fewer parameters and can generalize better in small chemical spaces than larger deep learning models, which may overfit in such spaces. Classical models are also often much faster to train and perform inference with using modest compute infrastructure, such as a laptop. They can also be easier to interpret because many descriptors have a chemical or physical rationale. I do not think classical machine learning belongs in the past. The method pool is broader now, and the researcher's or engineer’s understanding of the data and desired outputs should guide the modeling decision.

Source: www.news-medical.net ↗
05Your research has focused extensively on axon biology and small non-coding RNAs (sncRNAs). Can you explain why the study of sncRNAs in axons is significant and how it impacts our understanding of neuronal function? What impact does this have on drug discovery?

As an analogy, when the axon is scaled up to be the arm in a human body, you can think of the axon length in relation to the neuron's cell body as the equivalent distance from Nottingham to Paris. This significant length poses a logistical challenge for the neuron. For proteins to be expressed at the axon terminal, which is distant from the cell body, there's a requirement for translation regulation. In other words, there is a need for descentralized gene expression. Here, small non-coding RNAs play a pivotal role. Our work on microRNAs has shown their importance in spatial-temporal control of gene expression. This research aligns with the current interest in RNA biology and offers potential avenues for drug discovery, especially given the advances in RNA technologies post-covid.

Source: www.news-medical.net ↗
comparison

Comparisons

Side-by-side pages for commonly compared peptides and research compounds.

Source: peptideuniv.com
Research context

Read sources and limitations before applying a claim.

Longevity, Performance & Obesity Research

A research peptide formulation developed to investigate metabolic regulation, mitochondrial function, and nutrient-sensing pathways.

Source: mypeptidematch.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →